dict.md logo
Choose languages of interest
SELECT >>
English
German
Advertisement:
Translation
 
enEnglish deGerman
4 words
Chronic B-Cell Lymphocytic Leukemia Chronische lymphatische Leukämie
 
Advertisement:
 
Definition
 
enEnglish
chronic lymphocytic leukemia definition: chronic leukemia characterized by morphologically mature but immunologically less mature lymphocytes; manifested by an abnormal accumulation of these cells in blood, bone marrow, and lymphatic tissue.
chronic lymphocytic leukemia definition: A slowly progressing disease in which too many white blood cells (called lymphocytes) are found in the body.
Leukemia, Lymphocytic, Chronic, B-Cell definition: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.
Chronic Lymphocytic Leukemia definition: The most common type of chronic lymphoid leukemia. It comprises 90% of chronic lymphoid leukemias in the United States. Morphologically, the neoplastic cells are small, round B-lymphocytes. This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)
 
Examples
 

The resulting tumors differed from both those in the Eμ- MYC mice and those in Eμ- MYC /BCR HEL /sHEL mice, and resembled a subset of chronic B-cell lymphocytic leukemia (B-CLL).

Yosef Refaeli et al.

PLoS Biology 6 (6), 01 Jun 2008

B cell receptor BL Burkitt lymphoma DLBCL diffuse large B cell lymphoma GC germinal center HEL hen egg lysozyme NHL non-Hodgkin lymphoma References Jaffe E Harris NL Stein H Vardiman JW 2001 World Health Organization classification of tumors Pathology and genetics of tumors of hematopoietic and lymphoid tissues Kleihuis P Sobin L Lyon (France) Interantional Agency for Research on Cancer Leoncini L Delsol G Gascoyne RD Harris NL Pileri SA 2005 Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology Histopathology 46 241 255 15720410 Küppers R 2005 Mechanisms of B-cell lymphoma pathogenesis Nat Rev Cancer 5 251 262 15803153 Lam KP Kuhn R Rajewsky K 1997 In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death Cell 90 1073 1083 9323135 Neuberger MS 1997 Antigen receptor signaling gives lymphocytes a long life Cell 90 971 973 9323124 Kraus M Alimzhanov MB Rajewsky N Rajewsky K 2004 Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/Igbeta heterodimer Cell 117 787 800 15186779 Dameshek W Schwartz RS 1959 Leukemia and auto-immunization- some possible relationships Blood 14 1151 1158 13813891 Chapman CJ Mockridge CI Rowe M Rickinson AB Stevenson FK 1995 Analysis of VH genes used by neoplastic B cells in endemic Burkitt lymphoma shows somatic hypermutation and intraclonal heterogeneity Blood 85 2176 2181 7718888 Klein U Klein G Ehlin-Henriksson B Rajewsky K Kuppers R 1995 Burkitt's lymphoma is a malignancy of mature B-cells expressing somatically mutated V region genes Mol Med 1 495 505 8529116 Tamaru J Hummel M Marafioti T Kalvelage B Leonici L 1995 Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations Am J Pathol 147 1398 1407 7485402 Ottesmeier CH Thompsett AR Zhu D Wilkins BS Sweetenham JW 1998 Analysis of Vh genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression Blood 91 4292 4299 9596678 Lossos IS Alizabeth AA Eisen MB Chan WC Brown PO 2000 Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas Proc Natl Acad Sci U S A 97 10209 10213 10954754 Harris NL 1997 Principles of the revised Europan-American Lymphoma Classification (from the International Lymphoma Study group) Ann Oncol 8 Suppl 2 11 16 9209633 Chapman CJ Wright D Sevenson FK 1998 Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis Leuk Lymphoma 30 257 267 9713958 Quinn ER Chan CH Hadlock KG Foung SKH Flint M 2000 The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin's lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis Blood 98 3745 3749 11739181 De re V De Vita S Marzotto A Ruppolo M Glonghini A 2000 Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-hodgkin's lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia Blood 96 3578 3784 11071657 Lenz G Nagel I Siebert R Roschkle AV Sanger W 2007 Aberrant immunoglobulin class switch recombination and switch translocations in activated B-cell-like diffuse large B cell lymphoma J Exp Med 204 633 643 17353367 Bernard O Cory S Gerondakis S Webb E Adams JM 1983 Sequence of the murine and human cellular myc oncogenes and two modes of myc transcrption resulting from chromosome translocation in B lymphoid tumors EMBO J 2 2375 2383 6321164 Dalla-Favera R Bregni M Erikson J Patterson D Gallo RC 1983 Human c-myc onc gene is located on the region of chromosome 8 that is traslocated in Burkitt lymphoma cells Proc Natl Acad Sci U S A 79 7824 7827 6961453 Adams JM Harris AW Strasser A Ogilvy S Cory S 1999 Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector Oncogene 18 5268 5277 10498879 Hennighausen L Wall RJ Tillman U Li M Furth PA 1995 Conditional expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system J Cell Biochem 59 463 472 8749716 Furth PA St Onge L Boger H Gruss P Gossen M 1994 Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter Proc Natl Acad Sci U S A 91 9302 9306 7937760 Felsher DW Bishop JM 1999 Reversible tumorigenesis by MYC in hematopoietic lineages Mol Cell 4 199 207 10488335 Goodnow CC Brink RA Adams E 1991 Breakdown of self-tolerance in anergic B lymphocytes Nature 352 532 536 1830923 Goodnow CC Crosbie J Adelstein S Lavoie TB Smith-Gill SJ 1988 Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice Nature 334 676 682 3261841 Bannish G Fuentes-Panana EM Cambier JC Pear WS Monroe JG 2001 Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis J Exp Med 194 1583 1596 11733573 Langdon WY Harris AW Cory S Adams JM 1986 The c-myc oncogene preturbs B lymphocyte development in E-mu-myc transgenic mice Cell 47 11 18 3093082 Galler GR Mundt C Parker M Pelanda R Martensson IL 2004 Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components J Exp Med 199 1523 1532 15173209 Akagi K Miyazaki J Yamamura K 1992 Strain dependency of cell-type specificity and onset of lymphoma development in Emu-myc transgenic mice Jpn J Cancer Res 83 269 273 1582889 Prasad VS Temple MJ Davisson MT Akeson EC Sidman CL 1996 Heterogeneity of B-lymphoid tumors in E mu-myc transgenic mice Cytometry 23 131 139 8742172 Morse HC 3rd Anver MR Fredrickson TN Haines DC Harris AW 2002 Bethesda proposals for classification of lymphoid neoplasms in mice Blood 100 246 258 12070034 Watanabe-Fukunaga R Brannan CI Copeland NG Jenkins NA Nagata S 1992 Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 356 314 317 1372394 Jin L Stolpa JC Young RM Pugh-Bernard AE Refaeli Y 2008 MHC Class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death Immunol Lett 116 184 194 18194817 Ventura A Meissner A Dillon CP McManus M Sharp PA 2004 Cre-lox-reguated conditional RNA interference from transgenes Proc Natl Acad Sci U S A 101 10380 10385 15240889 Schiffer CA 2001 Treatment of high-grade lymphoid malignancies in adults Semin Hematol 38 22 26 11694948 Schmitt CA Fridman JS Yang M Lee S Baranov E 2002 A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy Cell 109 335 346 12015983 Ho S Clipstone N Timmerman L Northrop J Graef I 1996 The mechanism of action of cyclosporin A and FK506 Clin Immunol Immunopathol 80 S40 S45 8811062 Glynne R Akkaraju S Healy JI Rayner J Goodnow CC Mack DH 2000 How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis Nature 407 413 416 Gincras AC Raught B Sonenberg N 2003 mTor Signaling to translation Curr Top Microbiol Immunol 279 169 197 Tamir I Cambier JC 1998 Antigen receptor signaling: integration of protein tyrosine kinase functions Oncogene 17 1353 1364 9779983 Yan XZ Albesiano E Zanesi N Yancoupolous S Sawyer A 2006 B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia Proc Natl Acad Sci U S A 103 11713 11718 16864779 Hoyer KK French SW Turner DE Nguyen MTN Renard M 2002 Dysregulated Tcl-1 promotes multiple classes of mature B cell lymphoma Proc Natl Acad Sci U S A 99 14392 14397 12381789 Cattoretti G Pasqualucci L Ballon G Tam W Nandula SV 2005 Deregulated Bcl-6 expression recapitulates the pathogenesis of human diffuse large B cell lymphoma Cancer Cell 7 445 455 15894265 Pasqualucci L Bhagat G Jankovic M Compagno M Smith P 2007 AID is required for germinal center-derived lymphomagenesis Nat Genetics 40 108 112 18066064 Nussenzweig MC Schmidt EV Shaw AC Sinn E Campos-Torres J 1988 A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice Nature 336 446 450 3143076 Chin L Tam A Pomerantz J Wong M Holash J 1999 Essential role for oncogenic Ras in tumor maintenance Nature 400 468 472 10440378 Felsher DW Bishop JM 1999 Transient excess of MYC activity can elicit genomic instability and tumorigenesis Proc Natl Acad Sci U S A 96 3940 3944 10097142 Huettner CS Zhang P Van Etten RA Tenen DG 2000 Reversibility of acute B-cell leukemia induced by BCR-ABL1 Nat Genet 24 57 60 10615128 Fisher GH Wellen SL Klimstra D Lenczowski JM Tichelaar JW 2001 Induction of apoptotic regression of lung adenocarcinomas by regulation of K-Ras transgene in the presence and absence of tumor suppressor genes Genes Dev 15 3249 3262 11751631 Arvantis C Felsher DW 2006 Conditional transgenic models define how MYC initiates and maintains tumorigenesis Semin Cancer Biol 16 313 317 16935001 Refaeli Y Field KA Turner BC Trumpp A Bishop JM 2005 The proto-oncogene MYC can break B-cell tolerance Proc Natl Acad Sci U S A 102 4097 40102 15753301 Deng G Podack ER 1993 Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2 Proc Natl Acad Sci U S A 90 2189 2193 8460122 Kawahara A Minami Y Miyazaki T Ihle JN Taniguchi T 1995 Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction Proc Natl Acad Sci U S A 92 8724 8728 7568005 Shi Y Wang R Sharma A Gao C Collins M 1997 Dissociation of cytokine signals for proliferation and apoptosis J Immunol 159 5318 5328 9548471 Lord JD McIntosh BC Greenberg PD Nelson BH 2000 The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2 and bcl-x genes through the trans-activation domain of Stat5 J Immunol 164 2533 2541 10679091 Nossal GJ 1993 Tolerance and ways to break it Ann NY Acad Sci 690 34 41 8368749 Santana V Rose NR 1992 Neoplastic lymphoproliferation in autoimmune disease: an updated review Immunol Immunopath 63 205 213 Kassan SS Thomas TL Moutsopoulos HM Hoover R Kimberley RP 1978 Increased risk of lymphoma in sicca syndrome Ann Intern Med 89 888 892 102228 Charney J 1968 Production of self-directed antibody by tumour cells Nature 220 504 506 4301061 Heimer R Klein G 1976 Circulating immune complexes in sera of patients with Burkett's lymphoma and nasopharyngeal carcinoma Int J Cancer 18 310 316.61 783053 Vainio E Lenoir GM Franklin RM 1983 Autoantibodies in three populations of Burkitt's lymphoma patients Clin Exp Immunol 54 387 396 6317239 LaFond RE Eaton RB Watt RA Villee CA Actor JK 1992 Autoantibodies to c-myc protein: elevated levels in patients with African Burkitt's lymphoma and normal Ghanians Autoimmunity 13 215 224 1472633 Timuragaoglu A Duman A Ongut G Saka O Karadogan I 2000 The significance of autoantibodies in non-Hodgkin's lymphoma Leuk Lymphoma 40 119 122 11426612 Jezersek B Rudolf Z Novakovic S 2001 The circulating auto-antibodies to p53 protein in the follow-up of lymphoma patients Oncol Rep 8 77 81 11115573 Sallah S Sigounas G Vos P Wan JY Nguyen NP 2000 Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance Ann Oncol 11 1571 1477 11205465 Sokol RJ Hewitt S Stamps BK 1981 Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion center Brit Med J 282 2023 2027 Lossos IS Okada CY Warnke JM Greiner TC Levy R 2000 Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas Blood 95 1797 1803 10688840 Pasqualucci L Naumeister P Goosens T Nanjangud G Chaganti RS 2001 Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas Nature 412 341 346 11460166 Burkitt DP 1971 Epidemiology of Burkitt Lymphoma Proc R Soc Med 64 909 910 4329792 Schmidt EV Pattengale PK Weir L Leder P 1988 Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model Proc Natl Acad Sci U S A 85 6047 6051 3261863 Huang Y Snyder R Kligstein M Wickstrom E 1995 Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphothioate Mol Med 1 647 658 8529131 Kovalchuk AI Qi C-F Torrey TA Tadesse-Heath L Feigenbaum L 2000 Burkitt lymphoma in the mouse J Exp Med 192 1183 1190 11034608 Ruf IK Rhyne PW Yang C Cleveland JL Sample JT 2000 Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt's lymphoma cells independently of an effect of apoptosis J Virol 74 10223 10228 11024153 Rowe M Rooney CM Rickinson AB Lenoir GM Rupani H 1985 Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt lymphoma Int J Cancer 35 435 441 2985508 Okano M Gross TG 2001 From Burkitt lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases Pediatr Hematol Oncol 18 427 442 11594706 Hoffman B Amanullah A Shafarenko M Liebermann DS 2002 The proto-oncogene c-myc in hematopoietic development and leukemogenesis Oncogene 21 3414 3421 12032779 Robinson JE Brown N Andiman W Halliday K Francke U 1980 Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus N Eng J Med 302 1293 1297 McGrath MS Weissman IL 1979 AKR leukemogenesis: identification and biological significance of thymic lymphoma receptors for AKR retroviruses Cell 17 65 75 222476 Sklar J Cleary ML Thielemans K Gralow J Warnke R 1984 Biclonal B-cell lymphoma N Eng J Med 311 20 27 Magrath IT Shiramizu B 1989 Biology and treatment of small non-cleaved cell lymphoma Oncology 3 41 53 2578020 Nowell P 1976 The clonal evolution of tumor cell populations Science 194 23 28 959840 Hanahan D Weinberg RA 2000 The hallmarks of cancer Cell 100 57 70 10647931 Hecht JL Aster JC 2000 Molecular biology of Burkitt lymphoma J Clin Oncol 18 3707 3721 11054444 Kakufo GW Burkitt DP 1970 Burkitt lymphoma and malaria Int J Cancer 6 1 9 4319231 Facer C Khan G 1997 Detection of EBV RNA (EBER-1 and EBER-2) in malaria lymph nodes by in situ hybridization Microbiol Immunol 41 891 894 9444332 Klein U Klein G Ehlin-Henriksson B Rajewsky K Kuppers R 1995 Burkitt's lymphoma is a malignancy of mature B-cells expressing somatically mutated V region genes Mol Med 1 495 505 8529116 Boxer LM Dang CV 2001 Translocations involving c-myc and c-myc function Oncogene 20 5595 5610 11607812 Powell JD Zheng Y 2006 Dissecting the mechanism of T-cell anergy with immunophilin ligands Curr Opin Investig Drugs 7 1002 1007 Glynne R Akkaraju S Healy JI Rayner J Goodnow CC 2000 How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis Nature 407 413 416 Gincras AC Raught B Sonenberg N 2003 mTor Signaling to translation Curr Top Microbiol Immunol 279 169 197 Guba M Von Breitenbuch P Steinbauer M Koehl G Flegel S 2002 Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor Nat Med 8 128 135 11821896 Li HL Davis W Pure E 1999 Suboptimal cross-linking of antigen receptor induces Syk-dependent activation of p70S6 kinase through protein kinase C and phosphoinositol 3-kinase J Biol Chem 274 9812 9820 10092671 Donahue AC Fruman DA 2003 Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation J Immunol 170 5851 5860 12794110 Sawyers CL 2003 Will mTOR inhibitors make it as cancer drugs Cancer Cell 4 343 348 14667501 Pape KA Kouskoff V Nemazee D Tang HL Cyster JG 2003 Visualization of the genesis and fate of Isotype-switched B cells during a primary immune response J Exp Med 197 1677 1687 12796466 Hartley SB Crosbie J Brink R Kantor AB Basten A 1991 Elimination from peripheral tissues of self-reactive B lymphocytes recognizing membrane-bound antigens Nature 353 765 769 1944535 Kline GH Hayden TA Reigert P 2001 The initiation of B cell clonal expansion occurs independently of Pre-B cell receptor formation J Immunol 167 5136 5142 11673525 Reynolds A Leake D Boese Q Scrainge S Marshall WS 2004 Rational RNA design for siRNA interference Nat Biotechnol 22 326 333 14758366 Dull T Zufferey R Kelly M Mandel RJ Nguyen M 1998 A third-generation lentivirus vector with a conditional packaging system J Virol 72 8463 8471 9765382 Ye BH Cattoretti G Shen Q Zhang J Hawe N 1997 The Bcl-6 proto-oncogene controls germinal-center formation and Th2-type differentiation Nat Genet 16 161 170 9171827 Mumamatsu M Sankaranand VS Anant S Sugai M Kinoshita K 1999 Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells J Biol Chem 274 18470 18476 10373455 Albesiano E Messmer BT Damle RN Rai KR Chiorazzi N 2003 Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone Blood 102 3333 3339 12855567 Li Z Wang X Yu RY Ding BB Yu JJ 2005 Bcl-6 negatively regulates expression of the Nf-kappaB1 p105/p50 subunit J Immunol 174 205 214 15611242 Refaeli Y Van Parijs L Alexander SI Abbas AK 2002 Interferon-g (IFN-γ) is required for Fas-mediated apoptosis of T lymphocytes J Exp Med 196 999 1005 12370261 ¤a Current address: National Jewish Medical and Research Center, Department of Pediatrics, Program in Cell Biology, Denver, Colorado, United States of America

Yosef Refaeli et al.

PLoS Biology 6 (6), 01 Jun 2008

 
Publications
 
0 publications